Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04296396 · ClinicalTrials.gov registry record · Phase 3
Opioid Prescription After Cesarean Trial
A Phase 3 study, sponsored by The George Washington University Biostatistics Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 5,521
- Enrollment target
NCT04296396 is a Phase 3 study that has completed, run by The George Washington University Biostatistics Center. The registered enrollment target is 5,521 participants.
The verdict
NCT04296396, a Phase 3 study, has completed, sponsored by The George Washington University Biostatistics Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 5,521 participants
- Enrollment target
Study Summary
Non-inferiority randomized trial of 5,500 women with a cesarean delivery randomized prior to discharge to either an individualized opioid prescription protocol (IOPP) that includes shared decision making or to a fixed opioid prescription of 20 tablets of oxycodone 5mg.
Interventions
- DRUG 0 to 20 tablets of oxycodone 5mg
- DRUG Fixed opioid prescription
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,521 participants |
| Start Date | 2020-09-21 |
| Est. Completion | 2022-07-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04296396
The ClinicalTrials.gov registry entry for NCT04296396 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 5,521 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The George Washington University Biostatistics Center, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 0 to 20 tablets of oxycodone 5mg is the first listed.
NCT04296396 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04296396 about?
NCT04296396 is a clinical study titled "Opioid Prescription After Cesarean Trial". Non-inferiority randomized trial of 5,500 women with a cesarean delivery randomized prior to discharge to either an individualized opioid prescription protocol (IOPP) that includes shared decision making or to a fixed opioid prescription of 20 tablets of oxycodone 5mg.
What is the current status of trial NCT04296396?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 5,521 participants. The study started on 2020-09-21. Estimated completion is 2022-07-08.
What interventions are being tested in trial NCT04296396?
The interventions under investigation include: 0 to 20 tablets of oxycodone 5mg (DRUG), Fixed opioid prescription (DRUG).
Who is sponsoring clinical trial NCT04296396?
This trial is sponsored by The George Washington University Biostatistics Center, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.